These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30776362)

  • 1. Relative quantification of plasma N-glycans in type II congenital disorder of glycosylation patients by mass spectrometry.
    Barbosa EA; Fontes NDC; Santos SCL; Lefeber DJ; Bloch C; Brum JM; Brand GD
    Clin Chim Acta; 2019 May; 492():102-113. PubMed ID: 30776362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HILIC-UPLC-MS for high throughput and isomeric N-glycan separation and characterization in Congenital Disorders Glycosylation and human diseases.
    Messina A; Palmigiano A; Esposito F; Fiumara A; Bordugo A; Barone R; Sturiale L; Jaeken J; Garozzo D
    Glycoconj J; 2021 Apr; 38(2):201-211. PubMed ID: 32915358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma N-glycan profiling by mass spectrometry for congenital disorders of glycosylation type II.
    Guillard M; Morava E; van Delft FL; Hague R; Körner C; Adamowicz M; Wevers RA; Lefeber DJ
    Clin Chem; 2011 Apr; 57(4):593-602. PubMed ID: 21273509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MALDI-MS profiling of serum O-glycosylation and N-glycosylation in COG5-CDG.
    Palmigiano A; Bua RO; Barone R; Rymen D; Régal L; Deconinck N; Dionisi-Vici C; Fung CW; Garozzo D; Jaeken J; Sturiale L
    J Mass Spectrom; 2017 Jun; 52(6):372-377. PubMed ID: 28444691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALG12-CDG: novel glycophenotype insights endorse the molecular defect.
    Sturiale L; Bianca S; Garozzo D; Terracciano A; Agolini E; Messina A; Palmigiano A; Esposito F; Barone C; Novelli A; Fiumara A; Jaeken J; Barone R
    Glycoconj J; 2019 Dec; 36(6):461-472. PubMed ID: 31529350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometry glycophenotype characterization of ALG2-CDG in Argentinean patients with a new genetic variant in homozygosis.
    Papazoglu GM; Cubilla M; Pereyra M; de Kremer RD; Pérez B; Sturiale L; Asteggiano CG
    Glycoconj J; 2021 Apr; 38(2):191-200. PubMed ID: 33644825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum N-glycan and O-glycan analysis by mass spectrometry for diagnosis of congenital disorders of glycosylation.
    Xia B; Zhang W; Li X; Jiang R; Harper T; Liu R; Cummings RD; He M
    Anal Biochem; 2013 Nov; 442(2):178-85. PubMed ID: 23928051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Endoglycosidase H as a diagnostic tool for MAN1B1-CDG patients.
    Duvet S; Mouajjah D; Péanne R; Matthijs G; Raymond K; Jaeken J; Morava E; Foulquier F
    Electrophoresis; 2018 Dec; 39(24):3133-3141. PubMed ID: 29947113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Clinical Sensitivity and Specificity of Plasma Protein
    Chen J; Li X; Edmondson A; Meyers GD; Izumi K; Ackermann AM; Morava E; Ficicioglu C; Bennett MJ; He M
    Clin Chem; 2019 May; 65(5):653-663. PubMed ID: 30770376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein C-III O-glycoform profiling of 500 serum samples by matrix-assisted laser desorption/ionization mass spectrometry for diagnosis of congenital disorders of glycosylation.
    Wada Y; Okamoto N
    J Mass Spectrom; 2021 Apr; 56(4):e4597. PubMed ID: 32677746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel N-Tetrasaccharide in Patients with Congenital Disorders of Glycosylation, Including Asparagine-Linked Glycosylation Protein 1, Phosphomannomutase 2, and Mannose Phosphate Isomerase Deficiencies.
    Zhang W; James PM; Ng BG; Li X; Xia B; Rong J; Asif G; Raymond K; Jones MA; Hegde M; Ju T; Cummings RD; Clarkson K; Wood T; Boerkoel CF; Freeze HH; He M
    Clin Chem; 2016 Jan; 62(1):208-17. PubMed ID: 26430078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical glycomics for the diagnosis of congenital disorders of glycosylation.
    Abu Bakar N; Lefeber DJ; van Scherpenzeel M
    J Inherit Metab Dis; 2018 May; 41(3):499-513. PubMed ID: 29497882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of mass spectrometry in the diagnosis of congenital disorders of glycosylation.
    Sturiale L; Barone R; Garozzo D
    J Inherit Metab Dis; 2011 Aug; 34(4):891-9. PubMed ID: 21384227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Glycosylation of Serum IgG and Total Glycoproteins in MAN1B1 Deficiency.
    Saldova R; Stöckmann H; O'Flaherty R; Lefeber DJ; Jaeken J; Rudd PM
    J Proteome Res; 2015 Oct; 14(10):4402-12. PubMed ID: 26401844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometry for congenital disorders of glycosylation, CDG.
    Wada Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 838(1):3-8. PubMed ID: 16517226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution mass spectrometry glycoprofiling of intact transferrin for diagnosis and subtype identification in the congenital disorders of glycosylation.
    van Scherpenzeel M; Steenbergen G; Morava E; Wevers RA; Lefeber DJ
    Transl Res; 2015 Dec; 166(6):639-649.e1. PubMed ID: 26307094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosylation Analysis for Congenital Disorders of Glycosylation.
    Li X; Raihan MA; Reynoso FJ; He M
    Curr Protoc Hum Genet; 2015 Jul; 86():17.18.1-17.18.22. PubMed ID: 26132001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new strategy implementing mass spectrometry in the diagnosis of congenital disorders of N-glycosylation (CDG).
    Casetta B; Malvagia S; Funghini S; Martinelli D; Dionisi-Vici C; Barone R; Fiumara A; Donati MA; Guerrini R; la Marca G
    Clin Chem Lab Med; 2020 Aug; 59(1):165-171. PubMed ID: 32776892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissecting Total Plasma and Protein-Specific Glycosylation Profiles in Congenital Disorders of Glycosylation.
    Hipgrave Ederveen AL; de Haan N; Baerenfaenger M; Lefeber DJ; Wuhrer M
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rapid mass spectrometric strategy for the characterization of N- and O-glycan chains in the diagnosis of defects in glycan biosynthesis.
    Faid V; Chirat F; Seta N; Foulquier F; Morelle W
    Proteomics; 2007 Jun; 7(11):1800-13. PubMed ID: 17520685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.